Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aggression × Lymphoid × Clear all

Phase

Phase 2 4 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 625 Lymphoma, Non-Hodgkin 560 Precursor Cell Lymphoblastic Leukemia-Lymphoma 488 Leukemia, Lymphocytic, Chronic, B-Cell 468 Lymphoma, Large B-Cell, Diffuse 371 Lymphoma, Follicular 346 Lymphoma, Mantle-Cell 288 Leukemia 257 Burkitt Lymphoma 254 Hodgkin Disease 248 Leukemia, Myeloid, Acute 245 Lymphoma, B-Cell 234 Lymphoma, B-Cell, Marginal Zone 218 Recurrence 209 Multiple Myeloma 173 Neoplasms 172 Lymphoma, T-Cell, Cutaneous 143 Myelodysplastic Syndromes 139 Lymphoma, Large-Cell, Immunoblastic 134 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 126 Waldenstrom Macroglobulinemia 119 Lymphoma, Large-Cell, Anaplastic 116 Mycosis Fungoides 113 Sezary Syndrome 101 Immunoblastic Lymphadenopathy 83 Hematologic Neoplasms 81 Blast Crisis 74 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 73 Lymphoma, T-Cell, Peripheral 71 Lymphoma, T-Cell 66

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡